“showed a trend”

1D11 treatment alone showed a trend toward increased survival (median survival 45 days; p = 0.07 vs PBS control).

Both male and female Bdnf +/− showed a trend toward increased path length (p = 0.07, for both genders).

General health was significantly lower as a function of time since deployment after adjusting for probable PTSD (p = 0.03), age (p = 0.001) or gender (p < 0.001), and showed a trend when the combination of covariates were included in the model (p = 0.07).

Increased number of involved lymph nodes (more than 3) correlated with elevated expression of TWIST1 protein in LNM (P = 0.02) and showed a trend towards increased expression of TWIST1 mRNA in LNM (P = 0.07) and SNAIL protein in LNM (P = 0.07) (in Additional file 5 : Table S2).

Similar to litter mass loss, litter SIR showed a trend for a positive correlation with initial litter DOC in the presence of fauna (r 2 = 0.58, p = 0.07), while soil SIR tended to correlate negatively with initial litter lignin content (r 2 = 0.59, p = 0.07).

However, the neuropsychological group showed a significantly greater improvement on a line cancellation test of visual neglect ( t (62) = 2.1, P < 0.05) and a planned subanalysis for those with right hemisphere damage showed a trend towards better dressing outcome ( P = 0.07, one-tailed).

MAF of rs1061376 showed a trend towards a lower frequency in hypertensive patients [0.3 vs. 0.34; OR (T) = 0.83 (95%CI: 0.66 to 1.02; p = 0.07)].

The corresponding additive DAT1 and COMT effects on the visual N700 following non-target stimuli which had been preceded by the cue ‘A’ showed a trend for DAT1 (t = 1.8; p = 0.07) but no effect of COMT (t = 0.7; p = 0.48), while the interaction between DAT1 and COMT reached trend level in this case (t = 1.8; p = 0.08).

This effect was specific as c-MYC amplified cells lines were not resistant for Aurora kinase inhibition but rather showed a trend towards synthetic lethality, which is in agreement with our previous findings ( Supplementary Fig. 26 , p=0.07).

A Kaplan–Meier survival analysis showed a trend toward poor OS (3-year OS of 65% vs. 74%, p = 0.07) and significantly poor EFS overall (3-year EFS of 43% vs. 54%, p = 0.03) in low-FOXO3 expressers compared to patients with a high FOXO3 expression ( Figure 4 B).

3 E ), and the combination of MRK003 and gemcitabine showed a trend toward decreased proliferation (P = 0.07; Fig. 3 E ).

Compared to Gly placebo, the Gln group showed a trend toward a reduction in the mean mucositis score (Gln: 3.0 ± 0.3 versus Gly: 3.9 ± 0.4, P = 0.07) as well as a reduction in the number of d of IV narcotics use (12.1 ± 1.5 d versus Gly: 19.3 ± 2.8 d, P < 0.05) and TPN (17.3 ± 1.7 d versus Gly: 27.3 ± 3.6 d, P = 0.01).

Analysis of the data by original therapy assignment showed a trend toward improvement in 4-year DFS after treatment with exemestane compared with placebo (relative risk [RR] = 0.68; P = 0.07).

A separate post hoc analysis was done excluding one patient in the control group who died early (on day 3), and the analysis then showed a trend towards a further decrease in the mean stay in hospital with the antioxidant supplementation ( P =0.07).

CRLB of metabolites that were significantly different or showed a trend between the two groups are marked with *p<0.07, **p<0.001.

The naturally logarithmically transformed SIF showed a trend for being higher in cases with clinical evidence of DSP ( P = 0.07).

Patients who underwent an allograft showed a trend towards a higher transplant-related mortality, 16% versus 5%, p=0.07, and no difference in overall and event-free survivals.

Adapting to the same face showed a trend to decreased thresholds below baseline (p = 0.07), while adapting to a different face of either gender significantly increased thresholds above baseline (both p's<0.02).

Presence of BCL2 and MYC mRNA in plasma showed a trend to significant association with partial response in patients with DLBCL ( p = 0.07 for both; χ 2 test; Table 1 ).

In these subjects the associations between ppRV and these SNPs showed a trend toward significance only for S1 (mean ppRV = 132.1 for the common genotype, n = 379, and ppRV = 118.4 for the less common genotypes, n = 74, p value < 0.07).

Notably, the Bite + DSS group showed a trend toward less weight loss compared to DSS-only mice during recovery ( p = 0.07), suggesting possible modulation of disease course by bite exposure.

Regarding step variability, participants showed a trend toward reduced step length variability ( p = 0.070) and stride time variability ( p = 0.064), but they exhibited significantly increased step width variability ( p = 0.005) during POST. 3.1.2.

Subsyndromal PTSD subjects showed a trend for significantly higher heart-rate reactivity in comparison to non-PTSD participants ( p =.07), but not healthy controls ( p =.13).

Birds receiving biochar and/or saffron petal extract showed a trend ( P < 0.07) for higher TAC, compared with the control.

In the FD task, no significant differences were observed in the right-hand, left-hand, or both-hands subtasks (p = 0.66–0.89, d = -0.12 to 0.04), whereas the assembly subtask showed a trend toward lower performance in the CNNP group (p = 0.07, d = –0.51).